http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112402430-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e19f4be0158b0f34a8865653cb54fc4 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 |
| filingDate | 2020-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f7c86dadf008982dbbcfd619e87ddf5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a765cdbc0d801a58d966d0854ee8ef9 |
| publicationDate | 2021-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112402430-A |
| titleOfInvention | Application of alisol B-23-acetate in preventing and treating acute kidney injury |
| abstract | The invention belongs to the field of biology, and particularly relates to application of an FXR agonist in preparation of a medicine for preventing and/or treating kidney diseases. Specifically, the invention discloses an application of an FXR agonist in preparation of a medicine for preventing and/or treating kidney diseases. The FXR agonist is alisol B-23-acetate. Compared with the prior art, the invention firstly verifies that the alisol B-23-acetic ester can relieve acute kidney injury. The invention provides alisol B-23-acetate as an FXR agonist, which has the possibility of being applied to prevention and treatment of acute kidney injury. |
| priorityDate | 2020-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 158.